16 Jun 2022

Alvotech

NewsHeat chart

  • Week
  • Month
  • Year
  • Media news
  • Corp news
Click to unlock the chart

The data in the chart above is based on data derived from our proprietary XP calculation model and may be changed, adjusted and updated without prior notice

Company Valuation

  • Valuation
  • Share Price
  • Cumulative Funding

The data in the tables and charts is based on data from public sources and although we make every effort to compile the data, it may not coincide with the actual data of the issuer.

Funding Round
Funding Amount
Post-Money Valuation
Share Price

News related to Alvotech103

Filter by
Sort by
Alvotech
Jun 8, 2022Show on chart

Icelandic Biotech Alvotech Gets the Green Light : r/Spacstocks

r/Spacstocks - Icelandic Biotech Alvotech Gets the Green Light...

https://www.reddit.com/r/Spacstocks/comments/v78p54/icelandic_biotech_alvotech_gets_the_green_light/
Alvotech
Jun 8, 2022Show on chart

Alvotech and Oaktree Acquisition Corp. II Announce Shareholder ...

r/Spacstocks - Alvotech and Oaktree Acquisition Corp. II Announce Shareholder Approval of Business...

https://www.reddit.com/r/Spacstocks/comments/v76zn5/alvotech_and_oaktree_acquisition_corp_ii_announce/
Alvotech
May 19, 2022Show on chart

My account My Account Notifications Log In QQQ ––% DIA ––% SPY ...

Teva and Alvotech will share profit from the commercialization of these biosimilars. In March 2021, Abbvie sued Alvotech for allegedly misappropriating ...

https://www.benzinga.com/secfilings/21/07/22207123/teva-pharmaceutical-industries-ltd-quarterly-report-form10
Alvotech
May 19, 2022Show on chart

Teva Pharmaceutical Industries Ltd, TEVA:TLV summary - FT.com

Plus, unpacking the sustainable bond hype and Brad Pitt's affordable housing project hits trouble. January 31, 2022. European companies ...

https://markets.ft.com/data/equities/tearsheet/summary?s=TEVA:TLV
Alvotech
May 18, 2022Show on chart

OACB | Oaktree Acquisition Corp. II Cl A SEC Filings | MarketWatch

OACB and Alvotech S.A. and their directors and executive officers may be deemed participants in the solicitation of proxies from OACB's shareholders with ...

https://www.marketwatch.com/investing/stock/oacb/financials/secfilings?docid=15824980
Show more (98)

Investors5

AlvogenAlvogen
Baxter VenturesBaxter Ventures
Shinhan CapitalShinhan Capital
Athos CapitalAthos Capital
Aztiq PharmaAztiq Pharma